Veriheal
JANUARY 24, 2023
As cannabis enthusiasts, we’re all too familiar with the stigma surrounding its use and the hoops that have to be jumped through to get it into medical research trials. But recent news of the DEA’s approval of a cocaine derivative for Parkinson’s disease research has left us scratching our heads. So what gives?
Cannabis Law Report
MARCH 10, 2021
The post USA: Dr Suing DEA Over Right To Give Patients Psilocybin Treatment first appeared on Cannabis Law Report. Marijuana Moment reports A Seattle doctor hoping to expand access to psilocybin mushrooms for terminally ill cancer patients is taking… Read More.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NORML
AUGUST 2, 2019
.” To date, however, the agency has neither affirmed or denied any of the 26 applicants that have sought the DEA’s permission for a federal cultivation license. Read NORML’s new op-ed, “Three years ago the DEA said they would remove roadblocks to cannabis research — they still haven’t, here.).
Canna Law Blog
MAY 7, 2020
At the same time, because of the federal illegality of cannabis, the federal government has routinely denied third party requests for further research in regards to its potential medical benefits, among other health and safety impacts. These cannabis products are used by researchers in the U.S.
Cannabis Law Report
JUNE 13, 2022
Only appeals courts may hear challenges to DEA determinations, findings, and conclusions under the Controlled Substances Act, Judge Karen LeCraft Henderson of the US Court of Appeals for the D.C. The DEA in August 2020 issued a rule meant to conform existing regulations to amendments to the CSA in its treatment of hemp.
Veriheal
FEBRUARY 23, 2024
As the Drug Enforcement Administration (DEA) and federal government draw closer to moving cannabis from a Schedule I to a Schedule III substance , more groups have begun to put their weight behind the movement. The men and women who served in the U.S. Armed Forces often face difficult physical and mental challenges upon returning home.
MJ Business Attorneys
JUNE 29, 2018
The FDA’s approval of the drug is just one step toward getting Epidiolex on the market and available to doctors to prescribe as a treatment option. Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. In the recent case Hemp Industries Associations v.
Expert insights. Personalized for you.
98 
Let's personalize your content